» Articles » PMID: 11742859

Immune Mechanisms in Atherosclerosis

Overview
Date 2001 Dec 18
PMID 11742859
Citations 182
Authors
Affiliations
Soon will be listed here.
Abstract

Atherosclerosis is an inflammatory disease. Its lesions are filled with immune cells that can orchestrate and effect inflammatory responses. In fact, the first lesions of atherosclerosis consist of macrophages and T cells. Unstable plaques are particularly rich in activated immune cells, suggesting that they may initiate plaque activation. We have seen a rapid increase in the understanding of the mechanisms that govern the recruitment, differentiation, and activation of immune cells in atherosclerosis. Experimental research has identified several candidate antigens, and there are encouraging data suggesting that immune modulation as well as immunization can reduce the progression of the disease. This review provides an overview of our current understanding of the role of immune mechanisms in atherosclerosis.

Citing Articles

Inflammation and endothelial gene polymorphism are associated with ischemic stroke.

Chen W, Li J, Zhou J, Yi X, Chen H Front Neurol. 2025; 16:1465559.

PMID: 39974357 PMC: 11835671. DOI: 10.3389/fneur.2025.1465559.


Systems biology-based analysis exploring shared biomarkers and pathogenesis of myocardial infarction combined with osteoarthritis.

Luo Y, Liu Y, Xue W, He W, Lv D, Zhao H Front Immunol. 2024; 15:1398990.

PMID: 39086489 PMC: 11288954. DOI: 10.3389/fimmu.2024.1398990.


Associations of the circulating levels of cytokines with the risk of myeloproliferative neoplasms: a bidirectional mendelian-randomization study.

Xiong H, Zhang H, Bai J, Li Y, Li L, Zhang L BMC Cancer. 2024; 24(1):531.

PMID: 38671390 PMC: 11046808. DOI: 10.1186/s12885-024-12301-x.


Chemokine Fractalkine and Non-Obstructive Coronary Artery Disease-Is There a Link?.

Stangret A, Sadowski K, Jablonski K, Kochman J, Opolski G, Grabowski M Int J Mol Sci. 2024; 25(7).

PMID: 38612695 PMC: 11012077. DOI: 10.3390/ijms25073885.


The Heart of the Matter: Immune Checkpoint Inhibitors and Immune-Related Adverse Events on the Cardiovascular System.

Green C, Chacon J, Godinich B, Hock R, Kiesewetter M, Raynor M Cancers (Basel). 2023; 15(24).

PMID: 38136253 PMC: 10742007. DOI: 10.3390/cancers15245707.